GlassScriptPhysician profile
Michaela Skelly
NPI 1427097021
$20,564.37
in general payments reported to CMS, 2019-2025
73 companies · $3,278 in 2025
The $3,278 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,495 · 2020: $1,876 · 2021: $2,864 · 2022: $2,735 · 2023: $2,558 · 2024: $3,759 · 2025: $3,278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,465 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,464.98 |
| Education | $129.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,271.79 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $2,152.31 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $1,958.98 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Amgen INC. | $1,893.37 | 2019-2025 | Evenity, Repatha, Prolia |
| Sanofi-Aventis U.S. LLC | $981.73 | 2019-2023 | |
| Lilly USA, LLC | $803.46 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $777.10 | 2021-2025 | |
| Glaxosmithkline, LLC. | $749.00 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Pfizer INC. | $746.16 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $602.38 | 2019-2025 | Ajovy, Austedo Xr, Austedo |
| Astellas Pharma US INC | $578.81 | 2019-2025 | Veozah |
| Radius Health, INC. | $539.46 | 2019-2025 | Tymlos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $453.96 | 2019-2025 | Jardiance, Tradjenta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $439.86 | 2019-2025 | Xifaxan, Trulance |
| Inspire Medical Systems, INC. | $389.23 | 2024-2025 | Inspire |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $388.71 | 2019-2021 | |
| Edwards Lifesciences Corporation | $330.77 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Allergan, INC. | $285.84 | 2019-2020 | |
| Medtronic, INC. | $285.62 | 2021-2025 | Intellis Adaptivestim, Micra |
| Takeda Pharmaceuticals U.S.A., INC. | $274.29 | 2019-2025 | Trintellix |
| Corcept Therapeutics | $264.54 | 2020-2025 | Korlym |
| Amarin Pharma, INC. | $210.75 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $208.12 | 2021-2022 | |
| Echosens North America, INC. | $198.41 | 2023 | Fibroscan |
| Abbott Laboratories | $195.77 | 2019-2025 | Proclaim, Octrode |
| Boston Scientific Corporation | $181.56 | 2022-2024 | Superion Indirect Decompression System, Watchman Access System |
| Recordati_rare_diseases_inc. | $180.60 | 2023-2025 | Isturisa, Signifor Lar |
| Merck Sharp & Dohme LLC | $176.24 | 2020-2025 | Capvaxive, Gardasil 9, M-M-R II |
| Biohaven Pharmaceuticals, INC. | $162.08 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $159.61 | 2022 | |
| Intuitive Surgical, INC. | $114.55 | 2019-2022 | |
| Hologic Sales and Service, LLC | $106.66 | 2019-2024 | Aptima |
| Eisai INC. | $105.65 | 2020-2021 | |
| Esperion Therapeutics, INC. | $84.43 | 2020-2024 | Nexletol |
| Exact Sciences Corporation | $80.22 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amryt Pharma Holdings LTD | $73.31 | 2023 | Mycapssa |
| Kowa Pharmaceuticals America, INC. | $66.70 | 2019-2023 | Livalo |
| Janssen Pharmaceuticals, INC | $62.93 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $61.92 | 2025 | Gemtesa |
| Lucid Diagnostics INC. | $57.97 | 2022-2023 | |
| Topcon Healthcare Solutions, INC. | $55.01 | 2019 | |
| Horizon Therapeutics Plc | $54.51 | 2021-2023 | Tepezza |
| Xeris Pharmaceuticals, INC. | $53.66 | 2022-2023 | Gvoke Hypopen, Recorlev |
| Cleerly, INC. | $52.74 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Aimmune Therapeutics, INC. | $50.94 | 2024-2025 | Zenpep |
| Phathom Pharmaceuticals, INC. | $47.36 | 2024-2025 | Voquezna |
| Currax Pharmaceuticals LLC | $41.44 | 2020-2023 | Contrave, Nexletol, Nexlizet |
| Chiesi USA, INC. | $41.17 | 2025 | Mycapssa |
| Ultragenyx Pharmaceutical INC. | $33.95 | 2020-2021 | |
| Dexcom, INC. | $32.71 | 2022-2023 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $31.46 | 2022-2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $30.73 | 2025 | Caplyta |
| Cequr Corporation | $27.90 | 2023-2024 | Cequr Simplicity |
| Sandoz INC. | $27.22 | 2025 | |
| Nalpropion Pharmaceuticals LLC | $26.53 | 2019 | |
| Mayne Pharma Commercial LLC | $23.60 | 2023 | |
| Kyowa Kirin, INC. | $23.60 | 2024 | Crysvita |
| Idorsia Pharmaceuticals US INC | $20.83 | 2022 | |
| Impel Pharmaceuticals INC. | $18.67 | 2022 | |
| Insulet Corporation | $18.61 | 2024 | Omnipod |
| Alexion Pharmaceuticals, INC. | $18.49 | 2022 | |
| Lifescan, INC. | $18.21 | 2020 | |
| Alnylam Pharmaceuticals INC. | $17.60 | 2022 | |
| Nalu Medical, INC. | $17.06 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.11 | 2022 | |
| Phadia US INC. | $15.19 | 2022 | |
| Impulse Dynamics (USA) INC. | $14.93 | 2024 | Optimizer |
| Mylan Pharmaceuticals INC. | $14.74 | 2021 | |
| Amneal Pharmaceuticals LLC | $14.23 | 2019 | |
| Depuy Synthes Sales INC. | $13.68 | 2019 | |
| Nuvasive, INC. | $13.31 | 2021 | |
| Zyla Life Sciences, INC. | $12.03 | 2020 | |
| Therapeuticsmd, INC. | $11.30 | 2020 |
Drugs and devices associated with these payments
Wegovy $614Ozempic $580Evenity $572Breztri $540Airsupra $503Nurtec Odt $476Farxiga $464Kerendia $430Inspire $389Zavzpret $368Rybelsus $368Veozah $332Ubrelvy $309Repatha $274Tymlos $272Vraylar $266Ajovy $255Shingrix $245Prolia $229Mounjaro $212Fibroscan $198Korlym $192Edwards Sapien 3 Transcatheter Heart Valve (Thv) $188Jardiance $182Isturisa $181Xifaxan $178Intellis Adaptivestim $152Sapien 3 Ultra Resilia $143Qulipta $141Trelegy Ellipta $130Arexvy $125Zepbound $124Otezla $124Synthroid $120Mycapssa $114Superion Indirect Decompression System $112Signifor Lar $90.02Eliquis $89.48Trulance $89.42Prevnar 20 $84.30Paxlovid $72.84Cologuard Collection Kit $62.74Gemtesa $61.92Krystexxa $55.79Cleerly Ischemia $52.74Cleerly Labs $52.74Zenpep $50.94Aptima $48.40Voquezna $47.36Bexsero $36.99Comirnaty $35.82Austedo Xr $34.48Capvaxive $33.66Tepezza $32.50Caplyta $30.73Trintellix $30.57Optimizer $29.86Contrave $29.42Proclaim $27.92Cequr Simplicity $27.90Nexletol $27.78Austedo $23.83Crysvita $23.60Abrysvo $21.22Watchman Access System $20.96Gvoke Hypopen $20.90Menveo $18.81M-M-R II $18.64Vaxneuvance $18.64Gardasil 9 $18.64Varivax $18.64Omnipod $18.61Octrode $18.33Recorlev $17.87Entresto $17.76Dexcom G6 Transmitter $17.57The Cologuard Plus Collection Kit $17.48Steglatro $16.85Belsomra $16.85Livalo $15.47Linzess $15.15Micra $15.02Prevnar 13 $14.60Tradjenta $13.98Nexlizet $13.75Tavneos $13.69Soliqua 100/33 $12.80Toujeo $12.42Emgality $7.48
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michaela Skelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.